GENEVA, July 2 -- NOVARTIS AG filed a patent application (IB2025/063139) for “NLRP3 INFLAMMASOME INHIBITORS”. With publication no. WO/2026/133229, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 29/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....